Abstract
This presentation discusses the optimum magnetic resonance imaging (MRI) sequence for lung cancer assessment in a clinical setting, and the sensitivity and specificity of MRI (alone and in combination with diffusion-weighted imaging (DWI)-MR) compared with those of computed tomography (CT) and fluorodeoxyglucose-positron emission tomography (PET) for lung cancer staging. The role of perfusion studies (by CT or MRI), of DWI-MRI, blood oxygenation level dependent sequences and PET in defining the aggressiveness of lung tumours and in evaluating the response to radiochemotherapy is also discussed.
Original language | English |
---|---|
Journal | Cancer Imaging |
Volume | 10 |
Issue number | SPEC. ISS. A |
DOIs | |
Publication status | Published - 2010 |
Keywords
- Computed tomography
- Diffusion-weighted MRI
- Lung cancer
- Magnetic resonance imaging
ASJC Scopus subject areas
- Oncology
- Radiology Nuclear Medicine and imaging
- Radiological and Ultrasound Technology
- Medicine(all)